Validive (clonidine MBT) Trials

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Validive (clonidine MBT) / Monopar Therap

2021-000999-11: Study comparing the efficacy and safety of a clonidine tablet that sticks to the gum to a placebo tablet to prevent severe inflammation of the mouth caused by radiation treatment in patients with cancer in the middle of the throat Estudio que compara la eficacia y la seguridad de una tableta de clonidina que se pega a la encía versus tableta de placebo para prevenir una inflamación severa de la boca causada por el tratamiento de radiación en pacientes con cáncer en el medio de la garganta

Not yet recruiting

2/3

260

Europe

Validive (Clonidine HCl mucoadhesive buccal tablet (MBT)), Muco-adhesive buccal tablet

Monopar Therapeutics Inc., Monopar Therapeutics Inc.

Chemoradiotherapy (CRT)-induced severe oral mucositis (SOM) in patients with oropharyngeal cancer (OPC) Mucositis oral severa (MOS) inducida por quimioradioterapia (QRT) en pacientes con cáncer orofaríngeo (COF), Severe inflammation of the mouth caused by radiation treatment in patients with cancer in the middle of the throat Inflamación severa de la boca causada por el tratamiento de radiación en pacientes con cáncer en el medio de la garganta, Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]

VOICE, NCT04648020: Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.

Terminated

190

Europe, US

Clonidine HCl Mucoadhesive Buccal Tablet, Validive®, Placebo Mucoadhesive Buccal Tablet

Monopar Therapeutics

Chemoradiotherapy-Induced Severe Oral Mucositis

05/23



	Diseases Companies Products Productz Mechanisms of Action Sites